Teva Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Teva Pharma (TEVA) Reports In-Line Q3 EPS, Offer FY Guidance
November 5, 2020 7:15 AM ESTTeva Pharma (NYSE: TEVA) reported Q3 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $4 billion versus the consensus estimate of $4.07 billion.
GUIDANCE:
Teva Pharma sees FY2020 EPS of $2.40-$2.55, versus the consensus of... More



